Related references
Note: Only part of the references are listed.Cystic Renal Tumors: New Entities and Novel Concepts
Holger Moch
ADVANCES IN ANATOMIC PATHOLOGY (2010)
Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer
Corinne Dahinden et al.
CLINICAL CANCER RESEARCH (2010)
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma
Shams Halat et al.
MODERN PATHOLOGY (2010)
Alterations in VHL as potential biomarkers in renal-cell carcinoma
Lucy Gossage et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Tubulocystic Carcinoma of the Kidney Clinicopathologic Analysis of 31 Cases of a Distinctive Rare Subtype of Renal Cell Carcinoma
Mahul B. Amin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma
Van-Duc Luu et al.
CLINICAL CANCER RESEARCH (2009)
Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia
Peter Schraml et al.
MODERN PATHOLOGY (2009)
Clear cell papillary renal cell carcinoma - A distinct histopathologic and molecular genetic entity
Stefano Gobbo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation
Ian J. Frew et al.
EMBO JOURNAL (2008)
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
Jean-Jacques Patard et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Combined Vhlh and Pten mutation causes genital tract cystadenoma and squamous metaplasia
Ian J. Frew et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
pVHL: A Multipurpose Adaptor Protein
Ian J. Frew et al.
SCIENCE SIGNALING (2008)
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma
Bradley C. Leibovich et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The VHL tumor suppressor:: Riding tandem with GSK3β in primary cilium maintenance
Claudio R. Thoma et al.
CELL CYCLE (2007)
pVHL and GSK3β are components of a primary cilium-maintenance signalling network
Claudio R. Thoma et al.
NATURE CELL BIOLOGY (2007)
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2
Isabel Chu et al.
CELL (2007)
Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease
Cherie Stayner et al.
HUMAN MOLECULAR GENETICS (2006)
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer
RE Banks et al.
CANCER RESEARCH (2006)
Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma:: results from the Netherlands cohort study -: art. no. 57
KP van Houwelingen et al.
BMC CANCER (2005)
Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner
M Akbari et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Jiyong Liang et al.
CELL CYCLE (2003)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
P Schraml et al.
JOURNAL OF PATHOLOGY (2002)
Diverse effects of mutations in Exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity
WJ Hansen et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease
L Ostrom et al.
DEVELOPMENTAL BIOLOGY (2000)
Share Paper
